Urologic Oncology

  • Timothy L. Ratliff
  • William J. Catalona

Part of the Cancer Treatment and Research book series (CTAR, volume 19)

Table of contents

  1. Front Matter
    Pages i-xiii
  2. Gerald W. Chodak, Judah Folkman
    Pages 1-16
  3. Leland W. K. Chung, Timothy C. Thompson, Audrey K. Rocco, Abdulmaged M. Traish, Herbert H. Wotiz
    Pages 17-49
  4. Joseph R. Drago, Jack S. Elder
    Pages 51-87
  5. Jonathan Fleischmann, Warren D. W. Heston, William R. Fair, Michael M. Lieber
    Pages 89-109
  6. H. Barton Grossman, T. Ming Chu
    Pages 111-137
  7. Stephen C. Jacobs, Andrew C. Novick
    Pages 139-168
  8. David R. Kelley, William J. Catalona, Donald L. Lamm
    Pages 169-187
  9. Perinchery Narayan, William C. Dewolf, Wendell C. Speers
    Pages 189-209
  10. Timothy L. Ratliff, Amos Shapiro, William J. Catalona, Mathilde Krim
    Pages 211-253
  11. Randall G. Rowland, Michael A. S. Jewett
    Pages 255-277
  12. Arthur I. Sagalowsky, Marilyn S. Pollack
    Pages 279-305
  13. Richard D. Williams, Hedvig Hricak, Jeffrey H. Newhouse
    Pages 317-360
  14. Back Matter
    Pages 361-367

About this book


The study of genitourinary tumors is an area of recent rapid growth both in the understanding of disease processes and in the development of new diagnostic and therapeutic modalities. During rapid growth phases within any field, it is desirable to reflect on the current 'state of the art'. It is difficult even for experts in reputed areas of advancement to distinguish true advances from false leads, but it is far more difficult yet for those whose expertise lies in other areas to evaluate important advances. Thus, an objective assessment of evolving areas of investigation in the form of a comprehensive review is of considerable value. we have attempted to provide the reader with an over­ In this volume, view of some of the current areas of investigation in urologic oncology by experts in each area. There often is a tendency for invited papers in books of this nature to lack important critical peer review and therefore, suffer from a lack of objectivity. We have attempted to diminish this problem by the selection of two experts to discuss each subject. We believe that this format has improved the overall quality of the book for two reasons: 1) the know­ ledge of each contributor that his or her work would be reviewed by a peer 2) the fact that contributions by encourages more rigorous scholarship, and two experts, including the individual insights of each, provides a better per­ spective for the reader.


angiogenesis cancer carcinoma chemotherapy hormones imaging interferon kidney oncology surgery testis tumor urology

Editors and affiliations

  • Timothy L. Ratliff
    • 1
    • 2
  • William J. Catalona
    • 1
    • 2
  1. 1.Division of UrologyWashington University School of MedicineSt. LouisUSA
  2. 2.The Jewish Hospital of St. LouisSt. LouisUSA

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag US 1984
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4612-9795-6
  • Online ISBN 978-1-4613-2843-8
  • Series Print ISSN 0927-3042
  • Buy this book on publisher's site